𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticipation in inflammatory bowel disease: A phenomenon caused by an accumulation of confounders

✍ Scribed by Hampe, Jochen; Heymann, Kerstin; Kruis, Wolfgang; Raedler, Andreas; F�lsch, Ullrich R.; Schreiber, Stefan


Book ID
101212858
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
29 KB
Volume
92
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


Inflammatory bowel disease (IBD) has a definite genetic component as documented by epidemiological and linkage evidence. It shows an earlier onset of disease in children of affected patients than in their parents. This has lead to speculations about genetic anticipation in this disorder. 2,007 IBD patients with sporadic disease and 472 multiplex familial cases (including 103 affected parents and 99 children of affected patients) were evaluated with a multi-item questionnaire as part of a study of inflammatory bowel disease genetics. The Mann-Whitney U-test and the general linear model were used for analysis. Clinical characteristics such as presence of fistulae, stenoses, extraintestinal manifestations, and other parameters, which are related to the severity of the disease, were found to be similar between familial and sporadic cases of IBD (corrected P ≥ 0.31 for all tests). The meanage-of onset in children of affected patients was 19.4 years earlier than in their parents. However, the age of the parental cohort was significantly higher (27 years) and the diagnostic interval also longer (1.7 years). If these confounders are corrected in a general linear model, no significant difference is evident for the age-of-onset between the groups (P ≥ 0.52). There is no evidence for genetic anticipation in inflammatory bowel disease. The absence of genetic anticipation is consistent with the clinical similarity of familial and sporadic inflammatory bowel disease. This finding justifies the primary genetic analysis of familial disease under the assumption that their genetic background will be representative for all presentations of IBD. Am.


📜 SIMILAR VOLUMES


Identification of a novel autoantigen in
✍ Nathalie Vermeulen; Katrijn Op de Béeck; Severine Vermeire; Kristel Van Steen; G 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Background: Patients with inflammatory bowel disease (IBD) display immunoreactivity to self-antigens and microbial antigens. We used a protein microarray approach to identify novel autoantigens in IBD. Methods: ProtoArray Human Protein Microarray v4.0 containing 8268 human proteins from Invitrogen

Apolipoprotein A-IV is an independent pr
✍ Uli C. Broedl; Veronika Schachinger; Arno Lingenhel; Michael Lehrke; Renee Stark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Background: Apoa-iv, an apolipoprotein (apo) with antioxidant, antiatherogenic, and antiinflammatory properties, was recently demonstrated to inhibit dextran sulfate sodium (dss)-induced experimental colitis in mice. we therefore hypothesized that apoa-iv may be associated with disease activity

Role of growth factors in the developmen
✍ Pablo M. Linares; Javier P. Gisbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Studies on angiogenesis and lymphangiogenesis have gained special relevance in research into factors potentially influencing the pathogenesis and course of inflammatory bowel disease (IBD). The results of the few existing studies on the distribution and density of lymphatic vessels and blood vessels